Current diagnoses for Zika are made through molecular and serologic testing, and the CDC recommends both for infants who could be at risk. No commercial tests are available. CDC’s interim guidelines also include:
- How providers should report cases of infants carrying Zika to state and local health departments.
- Metrics for determining whether infants have microcephaly, a deformity in the size of the head linked to Zika that can cause severe developmental problems or death.
- How to manage care and treatment of infants who do not have microcephaly but whose mothers may have been infected with the virus at time of birth.
- Best practices for preventing mosquito bites for areas where active virus transmission is a risk.
More articles on infection control:
5 things to know about Zika
Search for better Zika diagnostics kicks into overdrive
Zika update: Spread warning, travel alerts, pregnancy recommendations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
